Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma

Experimental Neurology

Volumn 194, Issue 1, 2005, Pages 267-278

  Genovese, Tiziana ^a   Mazzon, Emanuela ^a   Di Paola, Rosanna ^a   Cannavò, Giuseppe ^a   Muià, Carmelo ^a   Bramanti, Placido ^a   Cuzzocrea, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Apoptosis; Cytokines; Motor recovery; Neutrophils infiltration; PPAR ligands; Spinal cord injury

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL FEATURE; CLIP; CONVALESCENCE; DURA MATER; EDEMA; IMMUNOREACTIVITY; KNOCKOUT MOUSE; LAMINECTOMY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; WILD TYPE;

AGE FACTORS; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NEUTROPHILS; PEROXYNITROUS ACID; PPAR ALPHA; SEVERITY OF ILLNESS INDEX; SPINAL CORD; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19344375176     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.03.003     Document Type: Article

References (61)

1. P.E. Beales, R. Liddi, A.E. Giorgini, A. Signore, E. Procaccini, K. Batchelor, and P. Pozzilli Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse Eur. J. Pharmacol. 357 1998 221 225
2. M.S. Beattie, A.A. Farooqui, and J.C. Bresnahan Review of current evidence for apoptosis after spinal cord injury J. Neurotrauma 17 2000 915 925
3. M.S. Beattie, G.E. Hermann, R.C. Rogers, and J.C. Bresnahan Cell death in models of spinal cord injury Prog. Brain Res. 137 2002 37 47
4. A. Benani, P. Kremarik-Bouillaud, A. Bianchi, P. Netter, A. Minn, and M. Dauca Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord J. Chem. Neuroanat. 25 2003 29 38
5. D. Bishop-Bailey, and T. Hla Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2 J. Biol. Chem. 274 1999 17042 17048
6. M.B. Bracken, M.J. Shepard, W.F. Collins, T.R. Holford, W. Young, D.S. Baskin, H.M. Eisenberg, E. Flamm, L. Leo-Summers, and J. Maroon A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury N. Engl. J. Med. 322 1990 1405 1411
7. B.S. Bregman, P.S. Diener, M. McAtee, H.N. Dai, and C. James Intervention strategies to enhance anatomical plasticity and recovery of function after spinal cord injury Adv. Neurol. 72 1997 257 275
8. B.S. Bregman, M. McAtee, H.N. Dai, and P.L. Kuhn Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat Exp. Neurol. 148 1997 475 494
9. B.S. Bregman, E. Broude, M. McAtee, and M.S. Kelley Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury Exp. Neurol. 149 1998 13 27
10. S.L. Carlson, M.E. Parrish, J.E. Springer, K. Doty, and L. Dossett Acute inflammatory response in spinal cord following impact injury Exp. Neurol. 151 1998 77 88
11. W.W. Chatham, R. Swaim, H. Frohsin Jr., L.W. Heck, E.J. Miller, and W.D. Blackburn Jr. Degradation of human articular cartilage by neutrophils in synovial fluid Arthritis Rheum. 36 1993 51 58
12. H. Cheng, Y. Cao, and L. Olson Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function [see comments] Science 273 1996 510 513
13. G. Chinetti, S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, J.C. Fruchart, J. Chapman, J. Najib, and B. Staels Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J. Biol. Chem. 273 1998 25573 25580
14. S. Cuzzocrea, D.P. Riley, A.P. Caputi, and D. Salvemini Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury Pharmacol. Rev. 53 2001 135 159
15. S. Cuzzocrea, R. Di Paola, E. Mazzon, T. Genovese, C. Muia, and A.P. Caputi WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock Shock 22 2004 340 346
16. S. Cuzzocrea, R. Di Paola, E. Mazzon, T. Genovese, C. Muia, T. Centorrino, and A.P. Caputi Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice Lab. Invest. 84 2004 1643 1654
17. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688
18. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli The PPARalpha-leukotriene B4 pathway to inflammation control Nature 384 1996 39 43
19. A. Diab, C. Deng, J.D. Smith, R.Z. Hussain, B. Phanavanh, A.E. Lovett-Racke, P.D. Drew, and M.K. Racke Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta (12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis J. Immunol. 168 2002 2508 2515
20. P.S. Diener, and B.S. Bregman Fetal spinal cord transplants support growth of supraspinal and segmental projections after cervical spinal cord hemisection in the neonatal rat J. Neurosci. 18 2 1998 779 793
21. P.S. Diener, and B.S. Bregman Fetal spinal cord transplants support the development of target reaching and coordinated postural adjustments after neonatal cervical spinal cord injury J. Neurosci. 18 2 1998 763 778
22. R.M. Evans The steroid and thyroid hormone receptor superfamily Science 240 1988 889 895
23. D.L. Feinstein, E. Galea, V. Gavriluk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Henkeka Peroxisome-proliferator activated receptor-g agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702
24. M. Fujiki, Z. Zhang, L. Guth, and O. Steward Genetic influences on cellular reactions to spinal cord injury: activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration J. Comp. Neurol. 371 3 1996 469 484
25. F.H. Geisler, F.C. Dorsey, and W.P. Coleman Recovery of motor function after spinal cord injury-A randomized placebo-controlled trial with GM-1 ganglioside N. Engl. J. Med. 324 26 1991 1829 1838
26. F.H. Geisler, F.C. Dorsey, and W.P. Coleman GM-1 ganglioside in human spinal cord injury J. Neurotrauma 9 2 1992 S517 S530
27. F.J. Gonzalez Recent update on the PPAR alpha-null mouse Biochimie 79 2-3 1997 139 144
28. K.A. Greene, F.F. Marciano, and V.K.H. Sonntag Pharmacological strategies in the treatment of spinal cord injuries: a critical review Crit. Rev. Neurosurg. 4 1994 254 264
29. M.E. Greene, B. Blumberg, O.W. McBride, H.F. Yi, K. Kronquist, K. Kwan, L. Hsieh, G. Greene, and S.D. Nimer Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expr. 4 1995 281 299
30. K.A. Greene, F.F. Marciano, and V.K.H. Sonntag Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord J. Spinal Disord. 9 5 1996 355 366
31. I. Inoue, K. Hayashi, F. Yagasaki, K. Nakamura, T. Matsunaga, H. Xu, K. Inukai, T. Awata, T. Komoda, and S. Katayama Apoptosis of endothelial cells may be mediated by genes of peroxisome proliferator-activated receptor gamma 1 (PPARgamma 1) and PPARalpha genes J. Atheroscler. Thromb. 10 2003 99 108
32. H. Ito, A. Nakano, M. Kinoshita, and A. Matsumori Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model Lab. Invest. 83 2003 1715 1721
33. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
34. M. Joshi, and M.G. Fehlings Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology J. Neurotrauma 19 2002 175 190
35. I. Klusman, and M.E. Schwab Effects of pro-inflammatory cytokines in experimental spinal cord injury Brain Res. 762 1-2 1997 173 184
36. Y.B. Lee, T.Y. Yune, S.Y. Baik, Y.H. Shin, S. Du, H. Rhim, E.B. Lee, Y.C. Kim, M.L. Shin, G.J. Markelonis, and T.H. Oh Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury Exp. Neurol. 166 1 2000 190 195
37. Y.L. Lee, K. Shih, P. Bao, R.S. Ghirnikar, and L.F. Eng Cytokine chemokine expression in contused rat spinal cord Neurochem. Int. 36 2000 417 425
38. D.M. McTigue, M. Tani, K. Krivacic, A. Chernosky, G.S. Kelner, D. Maciejewski, R. Maki, R.M. Ransohoff, and B.T. Stokes Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury J. Neurosci. Res. 53 1998 368 376
39. K.M. Mullane, R. Kraemer, and B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium J. Pharmacol. Methods 14 1985 157 167
40. G.J. Murphy, and J.C. Holder PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer Trends Pharmacol. Sci. 21 2000 469 474
41. C. Natarajan, and J.J. Bright Peroxisome proliferator-activated receptor-gamma agonists inhibits experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun. 3 2002 59 70
42. M. Niino, K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoé Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ J. Neuroimmunol. 116 2001 40 48
43. C. Profyris, S. Surindar, D. Cheema, M. Zang, F. Azari, K. Boyle, and S. Petratos Degenerative and regenerative mechanisms governing spinal cord injury Neurobiol. Dis. 15 2004 415 436
44. M. Ricote, A.C. Li, T.M. Willson, and C.K. Glass The peroxisome proliferator-activated receptor-g is a negative regulator of macrophage activation Nature 391 1998 79 82
45. R.A. Roberts, N.H. James, N.J. Woodyatt, N. Macdonald, and J.D. Tugwood Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha) Carcinogenesis 19 1998 43 48
46. L. Schnell, S. Fearn, H. Klassen, M.E. Schwab, and V.H. Perry Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord Eur. J. Neurosci. 11 1999 3648 3658
47. B. Schutte, R. Nuydens, H. Geerts, and F. Ramaekers Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells J. Neurosci. Methods 86 1998 63 69
48. G. Schwartz, and M.G. Fehlings Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole Prog. Brain Res. 137 2002 177 190
49. T.B. Shea Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner BioTechniques 16 1994 1126 1128
50. T. Sher, H.F. Yi, O.W. McBride, and F.J. Gonzalez cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 32 1993 5598 5604
51. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, I.P. Torra, P. Delerive, A. Fadel, G. Chinetti, J.C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators Nature 393 1998 790 793
52. C.G. Su, X. Wen, S.T. Bailey, W. Jiang, S.M. Rangwala, S.A. Keilbaugh, A. Flanigan, S. Murthy, M.A. Lazar, and G.D. Wu A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response J. Clin. Invest. 104 1999 383 389
53. C.H. Tator Update on the pathophysiology and pathology of acute spinal cord injury Brain Pathol. 5 1995 407 413
54. C.H. Tator, and M.G. Fehlings Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms J. Neurosurg. 75 1991 15 26
55. T. Tonai, K. Shiba, Y. Taketani, Y. Ohmoto, K. Murata, M. Muraguchi, H. Ohsaki, E. Takeda, and T. Nishisho A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats J. Neurochem. 78 2001 1064 1072
56. N.S. Wayman, M.C. McDonald, M.D. Threadgill, and C. Thiemermann 5 Amino isoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size Eur. J. Pharmacol. 430 2001 93 100
57. J. Xu, G.M. Kim, S. Chen, P. Yan, S.H. Ahmed, G. Ku, J.S. Beckman, X.M. Xu, and C.Y. Hsu iNOS and nitrotyrosine expression after spinal cord injury J. Neurotrauma 18 2001 523 532
58. W. Xu, L. Chi, R. Xu, Y. Ke, C. Luo, J. Cai, M. Qiu, D. Gozal, and R. Liu Increased production of reactive oxygen species contributes to motor neuron death in a compression mouse model of spinal cord injury Spinal Cord 2004 1 10
59. P. Yan, Q. Li, G. Kim, J. Xu, C.Y. Hsu, and X.M. Xu Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats J. Neurotrauma 18 2001 563 568
60. T.L. Yue, W. Bao, B.M. Jucker, J.L. Gu, A.M. Romanic, P.J. Brown, J. Cui, D.T. Thudium, R. Boyce, C.L. Burns-Kurtis, R.C. Mirabile, K. Aravindhan, and E.H. Ohlstein Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury Circulation 108 2003 2393 2399
61. Z. Zhang, L. Guth, and O. Steward Mechanisms of motor recovery after subtotal spinal cord injury: insights from the study of mice carrying a mutation (WldS) that delays cellular responses to injury Exp. Neurol. 149 1 1998 221 229